Bonnefoi HR - Search Results

1

Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT Trials.

Pagani O, Walley BA, Fleming GF, Colleoni M, Láng I, Gomez HL, Tondini C, Burstein HJ, Goetz MP, Ciruelos EM, Stearns V, Bonnefoi HR, Martino S, Geyer CE Jr, Chini C, Puglisi F, Spazzapan S, Ruhstaller T, Winer EP, Ruepp B, Loi S, Coates AS, Gelber RD, Goldhirsch A, Regan MM, Francis PA; SOFT and TEXT Investigators and the International Breast Cancer Study Group (a division of ETOP IBCSG Partners Foundation). Pagani O, et al. Among authors: bonnefoi hr. J Clin Oncol. 2023 Mar 1;41(7):1376-1382. doi: 10.1200/JCO.22.01064. Epub 2022 Dec 15. J Clin Oncol. 2023. PMID: 36521078 Free PMC article. Clinical Trial.

2

Priming low-dose chest radiotherapy followed by chemotherapy for limited small-cell lung cancer.

Bonnefoi H, Zulian GB, Mirimanoff RO, Mermillod B, Alberto P. Bonnefoi H, et al. Ann Oncol. 1994 Oct;5(8):771-2. doi: 10.1093/oxfordjournals.annonc.a058988. Ann Oncol. 1994. PMID: 7826914 Free article. Clinical Trial. No abstract available.

3

ASCO 2009: What's New in Breast Cancer Therapy?

Biganzoli L, Bonnefoi H, Cardoso F, Coleman R, Thürlimann B. Biganzoli L, et al. Breast Care (Basel). 2009;4(4):268-271. doi: 10.1159/000230677. Epub 2009 Aug 14. Breast Care (Basel). 2009. PMID: 20877666 Free PMC article. No abstract available.

4

A whole-genome sequence and transcriptome perspective on HER2-positive breast cancers.

Ferrari A, Vincent-Salomon A, Pivot X, Sertier AS, Thomas E, Tonon L, Boyault S, Mulugeta E, Treilleux I, MacGrogan G, Arnould L, Kielbassa J, Le Texier V, Blanché H, Deleuze JF, Jacquemier J, Mathieu MC, Penault-Llorca F, Bibeau F, Mariani O, Mannina C, Pierga JY, Trédan O, Bachelot T, Bonnefoi H, Romieu G, Fumoleau P, Delaloge S, Rios M, Ferrero JM, Tarpin C, Bouteille C, Calvo F, Gut IG, Gut M, Martin S, Nik-Zainal S, Stratton MR, Pauporté I, Saintigny P, Birnbaum D, Viari A, Thomas G. Ferrari A, et al. Nat Commun. 2016 Jul 13;7:12222. doi: 10.1038/ncomms12222. Nat Commun. 2016. PMID: 27406316 Free PMC article.

5

Erratum to: Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells.

Verbeke S, Richard E, Monceau E, Schmidt X, Rousseau B, Velasco V, Bernard D, Bonnefoi H, MacGrogan G, Iggo RD. Verbeke S, et al. Breast Cancer Res. 2015 Sep 16;17(1):126. doi: 10.1186/s13058-015-0612-1. Breast Cancer Res. 2015. PMID: 26376855 Free PMC article.

6

[First-line chemotherapy of breast cancer: new standard at specialized units].

Bonnefoi H, Vlastos G, Schaefer P. Bonnefoi H, et al. Rev Med Suisse Romande. 2003 May;123(5):309-12. Rev Med Suisse Romande. 2003. PMID: 15095715 Review. French. No abstract available.

7

An EORTC phase I study of epirubicin in combination with fixed doses of cyclophosphamide and infusional 5-fu (CEF-infu) as primary treatment of large operable or locally advanced/inflammatory breast cancer.

Bonnefoi H, Biganzoli L, Cufer T, Mauriac L, Hamilton A, Schaefer P, Piccart M. Bonnefoi H, et al. Breast Cancer Res Treat. 2001 Nov;70(1):55-63. doi: 10.1023/a:1012530607649. Breast Cancer Res Treat. 2001. PMID: 11768362 Clinical Trial.

8

p53 as a potential predictive factor of response to chemotherapy: feasibility of p53 assessment using a functional test in yeast from trucut biopsies in breast cancer patients.

Bonnefoi H, Ducraux A, Movarekhi S, Pelte MF, Bongard S, Lurati E, Iggo R. Bonnefoi H, et al. Br J Cancer. 2002 Mar 4;86(5):750-5. doi: 10.1038/sj.bjc.6600105. Br J Cancer. 2002. PMID: 11875738 Free PMC article.

9

Vaginal stenosis with hematocolpometra, complicating chronic graft versus host disease.

Anguenot JL, Ibéchéole V, Helg C, Piacenza JM, Dumps P, Bonnefoi H. Anguenot JL, et al. Eur J Obstet Gynecol Reprod Biol. 2002 Jul 10;103(2):185-7. doi: 10.1016/s0301-2115(02)00032-5. Eur J Obstet Gynecol Reprod Biol. 2002. PMID: 12069746 No abstract available.

10

Expression profiling in breast carcinoma: new insights on old prognostic factors?

Debled M, MacGrogan G, de Mascarel I, Brouste V, Bonnefoi H, Mauriac L. Debled M, et al. J Clin Oncol. 2007 Sep 20;25(27):4316-7; author reply 4317-8. doi: 10.1200/JCO.2007.12.6342. J Clin Oncol. 2007. PMID: 17878486 No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

144 results

Search Page